Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrik Nasr

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
ReplyPatrik Nasr, Hannes Hagström
Current Hepatology Reports|July 10, 2018
Natural History of NAFLD/NASHMattias Ekstedt, Patrik Nasr, Stergios Kechagias
JHEP Reports : Innovation in Hepatology|June 5, 2026
Assessing alcohol consumption in an era of direct alcohol markersCecilia Jönsson, Mattias Ekstedt, Patrik Nasr
Hepatology Communications|February 7, 2018
Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsiesPatrik Nasr, Simone Ignatova, Stergios Kechagias, et al.
The Lancet. Gastroenterology & Hepatology|September 7, 2024
Natural history and progression of metabolic dysfunction-associated steatotic liver diseaseHannes Hagström, Ying Shang, Hannes Hegmar, et al.
Current Pharmaceutical Design|March 12, 2020
Modifiers of Liver-Related Manifestation in the Course of NAFLDPatrik Nasr, Julia Blomdahl, Stergios Kechagias, et al.
Hepatology Communications|January 12, 2023
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLDJulia Blomdahl, Patrik Nasr, Mattias Ekstedt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2020
The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver diseasePatrik Nasr, Mats Fredrikson, Mattias Ekstedt, et al.
Hormones (Athens, Greece)|June 6, 2022
Non-invasive diagnosis and staging of non-alcoholic fatty liver diseaseStergios Kechagias, Mattias Ekstedt, Christian Simonsson, et al.
Hepatology (Baltimore, Md.)|April 11, 2022
Risk of cardiovascular disease and loss in life expectancy in NAFLDYing Shang, Patrik Nasr, Linnea Widman, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
ReplyPatrik Nasr, Hannes Hagström
Current Hepatology Reports|July 10, 2018
Natural History of NAFLD/NASHMattias Ekstedt, Patrik Nasr, Stergios Kechagias
JHEP Reports : Innovation in Hepatology|June 5, 2026
Assessing alcohol consumption in an era of direct alcohol markersCecilia Jönsson, Mattias Ekstedt, Patrik Nasr
Hepatology Communications|February 7, 2018
Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsiesPatrik Nasr, Simone Ignatova, Stergios Kechagias, et al.
The Lancet. Gastroenterology & Hepatology|September 7, 2024
Natural history and progression of metabolic dysfunction-associated steatotic liver diseaseHannes Hagström, Ying Shang, Hannes Hegmar, et al.
Current Pharmaceutical Design|March 12, 2020
Modifiers of Liver-Related Manifestation in the Course of NAFLDPatrik Nasr, Julia Blomdahl, Stergios Kechagias, et al.
Hepatology Communications|January 12, 2023
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLDJulia Blomdahl, Patrik Nasr, Mattias Ekstedt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2020
The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver diseasePatrik Nasr, Mats Fredrikson, Mattias Ekstedt, et al.
Hormones (Athens, Greece)|June 6, 2022
Non-invasive diagnosis and staging of non-alcoholic fatty liver diseaseStergios Kechagias, Mattias Ekstedt, Christian Simonsson, et al.
Hepatology (Baltimore, Md.)|April 11, 2022
Risk of cardiovascular disease and loss in life expectancy in NAFLDYing Shang, Patrik Nasr, Linnea Widman, et al.
Pageof 8